GKOS vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

GKOS

72.3
AI Score
VS
GKOS Wins

LUNG

55.1
AI Score

Investment Advisor Scores

GKOS

72score
Recommendation
BUY

LUNG

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GKOS LUNG Winner
Revenue 336.18M 43.34M GKOS
Net Income -38.16M -23.73M LUNG
Gross Margin 80.0% 78.0% GKOS
Net Margin -11.4% -54.8% GKOS
Operating Income -37.12M -22.01M LUNG
ROE -5.6% -60.6% GKOS
ROA -4.1% -20.7% GKOS
Total Assets 920.52M 114.73M GKOS
Cash 114.48M 55.84M GKOS
Current Ratio 5.04 4.32 GKOS
Free Cash Flow -4.40M -15.32M GKOS

Relative Price Performance (Last 90 Days)

GKOS 1M: -8.8% · 3M: +10.1% LUNG 1M: -19.7% · 3M: +23.6%

Current Technical Phase

GKOS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.9 · Price: $163.75

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.0 · Price: $1.83

Fundamentals Snapshot

Metric GKOS LUNG
Market Cap — —
Forward P/E 324.5 -1.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin -0.1% -0.4%
EPS -3.25 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GKOS is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.